VRXAW — VERAXA BIOTECH AG
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
截至Q3 2026,共 19 家机构在其最新 13F 申报中持有 VRXAW(VERAXA BIOTECH AG),合计申报市值 $773.23K,对应 6.67M 股。按股数计算较上季度增持 7.7%(+416.88K 股),申报市值环比下降 41.2%。持仓集中度较高:前五大持有人占申报市值的 81.0%,前十大的集中度为 93.1%。
与上一季度相比,4 家新建仓位、5 家加仓、3 家减仓、12 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q3 2026 末的持仓状态,并非实时交易。
VERAXA BIOTECH AG(VRXAW)的主要机构持有人包括 Yorkville Advisors Global, LP、LMR Partners LLP、ARISTEIA CAPITAL, L.L.C.,按 13F 申报市值在本页 31 家持有人中排名居前。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 19 | 6.67M | $773.23K | +7.7% |
| Q2 2026 | 27 | 9.09M | $1.01M | — |
表内 2 个季度中,机构持股合计减少 27%(Q2 2026 → Q3 2026)。
前 25 大机构持仓人(Q3 2026) — 19 家基金
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 1.60M | $176.58K | 0.01% | 新进 | |
| 1.09M | $120.13K | 0.00% | 新进 | |
| 1.06M | $116.38K | 0.00% | 新进 | |
| 976.08K | $115.67K | 0.00% | 新进 | |
| 875.00K | $96.51K | 0.00% | 新进 | |
| 658.14K | $72.59K | 0.00% | 新进 | |
| 485.36K | $53.53K | 0.00% | 新进 | |
| 350.26K | $43.78K | 0.00% | 新进 | |
| 253.21K | $27.93K | 0.00% | 新进 | |
| 200.00K | $22.06K | 0.00% | 新进 | |
| 193.61K | $21.36K | 0.00% | 新进 | |
| 185.33K | $20.44K | 0.01% | 新进 | |
| 183.65K | $20.26K | 0.00% | 新进 | |
| 150.00K | $16.55K | 0.00% | 新进 | |
| 142.08K | $15.67K | 0.00% | 新进 | |
| 125.00K | $13.79K | 0.00% | 新进 | |
| 102.75K | $11.33K | 0.00% | 新进 | |
| 100.00K | $11.03K | 0.00% | 新进 | |
| 100.00K | $11.03K | 0.00% | 新进 | |
| 98.36K | $10.85K | 0.00% | 新进 | |
| 59.99K | $6.62K | 0.00% | 新进 | |
| 43.67K | $4.82K | 0.00% | 新进 | |
| 19.89K | $2.19K | 0.00% | 新进 | |
| 25.57K | $2.00K | 0.00% | 新进 | |
| 10.27K | $1.13K | 0.00% | 新进 |
新建仓(Q3 2026)
- Yorkville Advisors Global, LP 309.90K 股 · $387.37K
- Kepos Capital LP 200.00K 股 · $12.02K
- PICTON MAHONEY ASSET MANAGEMENT 175.00K 股 · $10.52K
- K2 PRINCIPAL FUND, L.P. 154.95K 股 · $9.30K
完全清仓(较上季)
- LMR Partners LLP 卖出 1.09M 股 · $120.13K
- ARISTEIA CAPITAL, L.L.C. 卖出 976.08K 股 · $115.67K
- AQR Arbitrage LLC 卖出 658.14K 股 · $72.59K
- MILLENNIUM MANAGEMENT LLC 卖出 200.00K 股 · $22.06K
- WHITEBOX ADVISORS LLC 卖出 193.61K 股 · $21.36K
- Wealthspring Capital LLC 卖出 185.33K 股 · $20.44K
- TENOR CAPITAL MANAGEMENT Co., L.P. 卖出 150.00K 股 · $16.55K
- Lineage Point Capital LP 卖出 102.75K 股 · $11.33K
- BERKLEY W R CORP 卖出 59.99K 股 · $6.62K
- Schonfeld Strategic Advisors LLC 卖出 19.89K 股 · $2.19K
- HRT FINANCIAL LP 卖出 25.57K 股 · $2.00K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 卖出 10.27K 股 · $1.13K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 |
|---|---|---|
| Yorkville Advisors Global, LP | 309.90K | — |
| CSS LLC/IL | 1.62M | 1.60M |
| Magnetar Financial LLC | 995.49K | 1.06M |
| Alberta Investment Management Corp | 875.00K | 875.00K |
| Clear Street Group Inc. | 485.66K | 485.36K |
| MMCAP International Inc. SPC | 434.90K | 125.00K |
| JPMorgan Chase & Co | 352.47K | 350.26K |
| Verition Fund Management LLC | 269.66K | 43.67K |
| BNP PARIBAS FINANCIAL MARKETS | 238.40K | 253.21K |
| Kepos Capital LP | 200.00K | — |
| Westchester Capital Management, LLC | 183.65K | 183.65K |
| PICTON MAHONEY ASSET MANAGEMENT | 175.00K | — |
| K2 PRINCIPAL FUND, L.P. | 154.95K | — |
| Context Capital Management, LLC | 100.00K | 100.00K |
| Hudson Bay Capital Management LP | 100.00K | 100.00K |
| Yakira Capital Management, Inc. | 98.36K | 98.36K |
| Shaolin Capital Management LLC | 75.00K | 142.08K |
| WOLVERINE ASSET MANAGEMENT LLC | 6.95K | 2.92K |
| LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 194 | 194 |
| LMR Partners LLP | — | 1.09M |
常见问题
Which funds hold VRXAW?
As of 2026-Q3, 19 institutional funds reported holding VRXAW (VERAXA BIOTECH AG) in SEC 13F filings, with a combined reported value of $773.23K.
How many shares of VRXAW do institutions own?
13F filers reported 6.67M shares of VRXAW, worth $773.23K in aggregate at the end of 2026-Q3.
Is institutional ownership of VRXAW rising or falling?
Share counts moved +7.7% versus the prior quarter — accumulation.
Who are the top institutional holders of VRXAW?
The largest 13F holders are Yorkville Advisors Global, LP, LMR Partners LLP, ARISTEIA CAPITAL, L.L.C., CSS LLC/IL, AQR Arbitrage LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of VERAXA BIOTECH AG?
The major shareholders of VERAXA BIOTECH AG (VRXAW) by reported 13F value are Yorkville Advisors Global, LP, LMR Partners LLP, ARISTEIA CAPITAL, L.L.C., CSS LLC/IL, AQR Arbitrage LLC, among 31 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.